Home / Latest Reports / Stem Cells Market

Stem Cells Market by Type, Application, Key Players and Regions - Global Industry Analysis & Forecast to 2027

Published On : August 2022 Pages : 145 Category: Pharma & Healthcare Report Code : HC0817414

Request Sample Inquiry Before Buying Request for Customization Check Discount

The global Stem Cells Market is valued at USD XX billion in 2021 and is projected to reach USD XX billion by the end of 2027, growing at a CAGR of XX% during the period 2022 to 2027.

The report exhibit detail coverage of Stem Cells industry and market trends. The report also analyses present and past market values to forecast potential market through the forecast period between 2017-2022. This research study of Stem Cells Market involved the extensive usage of both primary and secondary data sources. This includes the study of various parameters affecting the industry, including the government policy, market environment, competitive landscape, historical data, present trends in the market, technological innovation, upcoming technologies and the technical progress in related industry.

In addition, the report provides insight into main drivers, challenges, opportunities and risk of the market and strategies of suppliers. Key players are profiled as well. Overall, this report covers the historical situation, present status and the future prospects of the global Stem Cells Market for 2017-2022.

Crystal Market Research envisions that the span of the Stem Cells Market will develop amid the estimated time frame as the Compound Annual Growth Rate boosts significantly. The objective of the market research report is the current status of the market and in accordance classifies it into a few portions. The report takes into consideration the prime market players in every area from over the globe.

Our research study analyses the size of the global market of Stem Cells in primary regions such as North America, South America, Middle East & Africa, Asia Pacific and Europe. It also classifies the Stem Cells Market by key manufacturers, region, type and application. Furthermore, this study examines in the status of the market, market share, future trends, growth rate, competitive landscape, opportunities, market driving factors and restraints, and challenges.

To stay updated with the latest technology and functions of the industry, Crystal Market Research regularly performs interviews with several industry experts and visits for its expert research analysts. The data sources include but not limited to reports of company’s, international organizations and governments, MMI market surveys, and related industry news.

This report forecasts revenue growth at global, regional & country levels and provides an analysis on the industry trends in each of the sub-segments from 2017 to 2027. This report has segmented the Stem Cells Market on the basis of fabric, product, application, and region:

By Region

  • North America (US, Canada)
  • Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
  • Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
  • South America (Brazil, Mexico, Columbia, Rest of South America)
  • Middle East and Africa (Saudi Arabia, UAE, South Africa, Turkey, Rest of MEA)

Competitive Analysis                    

The major players in the market are profiled in detail in view of qualities, for example, company portfolio, business strategies, financial overview, recent developments, and share of the overall industry.

  • BioTime, Inc.
  • Cellular Engineering Technologies
  • Astellas Pharma Inc.
  • ThermoGenesis Holdings, Inc
  • STEMCELL Technologies Inc.
  • Pluristem Therapeutics Inc
  • Seneca Biopharmaceuticals, Inc.
  • Opexa Therapeutics, Inc.
  • Precious Cells International Ltd
  • Virgin Health Bank
  • Mesoblast Ltd
  • ReNeuron Group plc

Market Classification

·        Stem Cells Market, By Type, Estimates and Forecast, 2017-2022 ($Million)

o   Adult Stem Cells

o   Human Embryonic Stem Cells

o   Induced Pluripotent Stem Cells

o   Very Small Embryonic Like Stem Cells

·        Stem Cells Market, By Application, Estimates and Forecast, 2017-2022 ($Million)

o   Regenerative Medicine

o   Drug Discovery and Development

Table of Contents

1.     Introduction

1.1.  Report Description

1.2.  Research Methodology

1.2.1.     Data Mining

1.2.2.     Market Modeling and Forecasting

1.2.3.     Data Validation

1.2.4.     Industry Analysis

2.     Market Dashboard

3.     Market Overview

3.1.  Introduction

3.1.1.     Market Definition

3.1.2.     Market Segmentation

3.2.  Market Dynamics

3.2.1.     Drivers

3.2.2.     Restraints

3.2.3.     Opportunities

3.2.4.     Challenges

4.     Stem Cells Market, By Type

4.1.  Introduction

4.2.  Stem Cells Market and Market Growth Rate By Type (2017-2022)

4.3.  Adult Stem Cells

4.3.1.     Global Adult Stem Cells Market and Growth Rate (2017-2022)

4.3.  Human Embryonic Stem Cells

4.3.1.     Global Human Embryonic Stem Cells Market and Growth Rate (2017-2022)

4.3.  Induced Pluripotent Stem Cells

4.3.1.     Global Induced Pluripotent Stem Cells Market and Growth Rate (2017-2022)

4.3.  Very Small Embryonic Like Stem Cells

4.3.1.     Global Very Small Embryonic Like Stem Cells Market and Growth Rate (2017-2022)

5.     Stem Cells Market, By Application

5.1.  Introduction

5.2.  Stem Cells Market and Market Growth Rate By Application (2017-2022)

5.3.  Regenerative Medicine

5.3.1.     Global Regenerative Medicine Market and Growth Rate (2017-2022)

5.3.  Drug Discovery and Development

5.3.1.     Global Drug Discovery and Development Market and Growth Rate (2017-2022)

7.     Stem Cells Market, By Region

7.1.  Introduction

7.2.  Stem Cells Market and Growth Rate By Regions

6.3.  North America

7.3.1.     North America Stem Cells Market and Growth Rate (2017-2022))

7.3.2.     North America Stem Cells Market By Type (2017-2022)

7.3.2.     North America Stem Cells Market By Application (2017-2022)

7.3.4.     North America Stem Cells Market By Country (2017-2022)

7.3.5.     United States

7.3.5.1.United States Stem Cells Market and Growth Rate (2017-2022)

7.3.5.2.United States Stem Cells Market By Type (2017-2022)

7.3.5.2.United States Stem Cells Market By Application (2017-2022)

7.3.5.     Canada

7.3.5.1.Canada Stem Cells Market and Growth Rate (2017-2022)

7.3.5.2.Canada Stem Cells Market By Type (2017-2022)

7.3.5.2.Canada Stem Cells Market By Application (2017-2022)

6.3.  Europe

8.3.1.     Europe Stem Cells Market and Growth Rate (2017-2022))

8.3.2.     Europe Stem Cells Market By Type (2017-2022)

8.3.2.     Europe Stem Cells Market By Application (2017-2022)

8.3.4.     Europe Stem Cells Market By Country (2017-2022)

8.3.5.     Germany

8.3.5.1.Germany Stem Cells Market and Growth Rate (2017-2022)

8.3.5.2.Germany Stem Cells Market By Type (2017-2022)

8.3.5.2.Germany Stem Cells Market By Application (2017-2022)

8.3.5.     France

8.3.5.1.France Stem Cells Market and Growth Rate (2017-2022)

8.3.5.2.France Stem Cells Market By Type (2017-2022)

8.3.5.2.France Stem Cells Market By Application (2017-2022)

8.3.5.     UK

8.3.5.1.UK Stem Cells Market and Growth Rate (2017-2022)

8.3.5.2.UK Stem Cells Market By Type (2017-2022)

8.3.5.2.UK Stem Cells Market By Application (2017-2022)

8.3.5.     Russia

8.3.5.1.Russia Stem Cells Market and Growth Rate (2017-2022)

8.3.5.2.Russia Stem Cells Market By Type (2017-2022)

8.3.5.2.Russia Stem Cells Market By Application (2017-2022)

8.3.5.     Italy

8.3.5.1.Italy Stem Cells Market and Growth Rate (2017-2022)

8.3.5.2.Italy Stem Cells Market By Type (2017-2022)

8.3.5.2.Italy Stem Cells Market By Application (2017-2022)

8.3.5.     Rest of Europe

8.3.5.1.Rest of Europe Stem Cells Market and Growth Rate (2017-2022)

8.3.5.2.Rest of Europe Stem Cells Market By Type (2017-2022)

8.3.5.2.Rest of Europe Stem Cells Market By Application (2017-2022)

6.3.  Asia-Pacific

9.3.1.     Asia-Pacific Stem Cells Market and Growth Rate (2017-2022))

9.3.2.     Asia-Pacific Stem Cells Market By Type (2017-2022)

9.3.2.     Asia-Pacific Stem Cells Market By Application (2017-2022)

9.3.4.     Asia-Pacific Stem Cells Market By Country (2017-2022)

9.3.5.     China

9.3.5.1.China Stem Cells Market and Growth Rate (2017-2022)

9.3.5.2.China Stem Cells Market By Type (2017-2022)

9.3.5.2.China Stem Cells Market By Application (2017-2022)

9.3.5.     Japan

9.3.5.1.Japan Stem Cells Market and Growth Rate (2017-2022)

9.3.5.2.Japan Stem Cells Market By Type (2017-2022)

9.3.5.2.Japan Stem Cells Market By Application (2017-2022)

9.3.5.     Korea

9.3.5.1.Korea Stem Cells Market and Growth Rate (2017-2022)

9.3.5.2.Korea Stem Cells Market By Type (2017-2022)

9.3.5.2.Korea Stem Cells Market By Application (2017-2022)

9.3.5.     India

9.3.5.1.India Stem Cells Market and Growth Rate (2017-2022)

9.3.5.2.India Stem Cells Market By Type (2017-2022)

9.3.5.2.India Stem Cells Market By Application (2017-2022)

9.3.5.     Southeast Asia

9.3.5.1.Southeast Asia Stem Cells Market and Growth Rate (2017-2022)

9.3.5.2.Southeast Asia Stem Cells Market By Type (2017-2022)

9.3.5.2.Southeast Asia Stem Cells Market By Application (2017-2022)

9.3.5.     Rest of Asia-Pacific

9.3.5.1.Rest of Asia-Pacific Stem Cells Market and Growth Rate (2017-2022)

9.3.5.2.Rest of Asia-Pacific Stem Cells Market By Type (2017-2022)

9.3.5.2.Rest of Asia-Pacific Stem Cells Market By Application (2017-2022)

6.3.  South America

10.3.1.     South America Stem Cells Market and Growth Rate (2017-2022))

10.3.2.     South America Stem Cells Market By Type (2017-2022)

10.3.2.     South America Stem Cells Market By Application (2017-2022)

10.3.4.     South America Stem Cells Market By Country (2017-2022)

10.3.5.     Brazil

10.3.5.1.Brazil Stem Cells Market and Growth Rate (2017-2022)

10.3.5.2.Brazil Stem Cells Market By Type (2017-2022)

10.3.5.2.Brazil Stem Cells Market By Application (2017-2022)

10.3.5.     Mexico

10.3.5.1.Mexico Stem Cells Market and Growth Rate (2017-2022)

10.3.5.2.Mexico Stem Cells Market By Type (2017-2022)

10.3.5.2.Mexico Stem Cells Market By Application (2017-2022)

10.3.5.     Columbia

10.3.5.1.Columbia Stem Cells Market and Growth Rate (2017-2022)

10.3.5.2.Columbia Stem Cells Market By Type (2017-2022)

10.3.5.2.Columbia Stem Cells Market By Application (2017-2022)

10.3.5.     Rest of South America

10.3.5.1.Rest of South America Stem Cells Market and Growth Rate (2017-2022)

10.3.5.2.Rest of South America Stem Cells Market By Type (2017-2022)

10.3.5.2.Rest of South America Stem Cells Market By Application (2017-2022)

6.3.  Middle East and Africa

11.3.1.     Middle East and Africa Stem Cells Market and Growth Rate (2017-2022))

11.3.2.     Middle East and Africa Stem Cells Market By Type (2017-2022)

11.3.2.     Middle East and Africa Stem Cells Market By Application (2017-2022)

11.3.4.     Middle East and Africa Stem Cells Market By Country (2017-2022)

11.3.5.     Saudi Arabia

11.3.5.1.Saudi Arabia Stem Cells Market and Growth Rate (2017-2022)

11.3.5.2.Saudi Arabia Stem Cells Market By Type (2017-2022)

11.3.5.2.Saudi Arabia Stem Cells Market By Application (2017-2022)

11.3.5.     United Arab Emirates

11.3.5.1.United Arab Emirates Stem Cells Market and Growth Rate (2017-2022)

11.3.5.2.United Arab Emirates Stem Cells Market By Type (2017-2022)

11.3.5.2.United Arab Emirates Stem Cells Market By Application (2017-2022)

11.3.5.     South Africa

11.3.5.1.South Africa Stem Cells Market and Growth Rate (2017-2022)

11.3.5.2.South Africa Stem Cells Market By Type (2017-2022)

11.3.5.2.South Africa Stem Cells Market By Application (2017-2022)

11.3.5.     Rest of Middle East and Africa

11.3.5.1.Rest of Middle East and Africa Stem Cells Market and Growth Rate (2017-2022)

11.3.5.2.Rest of Middle East and Africa Stem Cells Market By Type (2017-2022)

11.3.5.2.Rest of Middle East and Africa Stem Cells Market By Application (2017-2022)

7.     Company Profiles

7.1.  BioTime, Inc.

7.1.1.     Business Overview

7.1.1.     Service Portfolio

7.1.1.     Strategic Developments

7.1.1.     Financial Overview

7.1.  Cellular Engineering Technologies

7.1.1.     Business Overview

7.1.1.     Service Portfolio

7.1.1.     Strategic Developments

7.1.1.     Financial Overview

7.1.  Astellas Pharma Inc.

7.1.1.     Business Overview

7.1.1.     Service Portfolio

7.1.1.     Strategic Developments

7.1.1.     Financial Overview

7.1.  ThermoGenesis Holdings, Inc

7.1.1.     Business Overview

7.1.1.     Service Portfolio

7.1.1.     Strategic Developments

7.1.1.     Financial Overview

7.1.  STEMCELL Technologies Inc.

7.1.1.     Business Overview

7.1.1.     Service Portfolio

7.1.1.     Strategic Developments

7.1.1.     Financial Overview

7.1.  Pluristem Therapeutics Inc

7.1.1.     Business Overview

7.1.1.     Service Portfolio

7.1.1.     Strategic Developments

7.1.1.     Financial Overview

7.1.  Seneca Biopharmaceuticals, Inc.

7.1.1.     Business Overview

7.1.1.     Service Portfolio

7.1.1.     Strategic Developments

7.1.1.     Financial Overview

7.1.  Opexa Therapeutics, Inc.

7.1.1.     Business Overview

7.1.1.     Service Portfolio

7.1.1.     Strategic Developments

7.1.1.     Financial Overview

7.1.  Precious Cells International Ltd

7.1.1.     Business Overview

7.1.1.     Service Portfolio

7.1.1.     Strategic Developments

7.1.1.     Financial Overview

7.1.  Virgin Health Bank

7.1.1.     Business Overview

7.1.1.     Service Portfolio

7.1.1.     Strategic Developments

7.1.1.     Financial Overview

7.1.  Mesoblast Ltd

7.1.1.     Business Overview

7.1.1.     Service Portfolio

7.1.1.     Strategic Developments

7.1.1.     Financial Overview

7.1.  ReNeuron Group plc

7.1.1.     Business Overview

7.1.1.     Service Portfolio

7.1.1.     Strategic Developments

7.1.1.     Financial Overview

Research Methodology

We use both primary as well as secondary research for our market surveys, estimates and for developing forecast. Our research process commence by analyzing the problem which enable us to design the scope for our research study. Our research process is uniquely designed with enough flexibility to adjust according to changing nature of products and markets, while retaining core element to ensure reliability and accuracy in research findings. We understand both macro and micro-economic factors to evaluate and forecast different market segments.

Data Mining

Data is extensively collected through various secondary sources such as annual reports, investor presentations, SEC filings, and other corporate publications. We also refer trade magazines, technical journals, paid databases such as Factiva and Bloomberg, industry trade journals, scientific journals, and social media data to understand market dynamics and industry trends. Further, we also conduct primary research to understand market drivers, restraints, opportunities, challenges, and competitive scenario to build our analysis.

Data Collection Matrix

Data Collection Matrix

Supply Side

Demand Side

Primary Data Sources
  • Manufacturers
  • Distributors & Wholesalers
  • GPOs
  • Physicians/Specialist
  • Healthcare Providers
  • Consumers

Secondary Data Sources
  • Annual Reports/SEC Filings/ Investor Presentations/ Press Releases
  • Government/Associations Publications
  • Case Studies
  • Reference Customers

 

Market Modeling and Forecasting

We use epidemiology and capital equipment-based models to forecast market size of different segments at country and regional level.

  • Epidemiology-based Forecasting Model: This method uses epidemiology data gathered through various publications and from physicians to estimate population of patients, flow of treatment of individual disease and therapies. The data collected through this method includes statics on incidence of disease, population suffering from disease, and treatment population. This method is used to understand:
  • Number of patients for particular device or medical procedure and
  • Repeated use of particular device depending on health and condition of patient
  • Capital-based Forecasting Model: This method of forecasting is based on number of replacements, installed-based and new sales of capital equipment used in various healthcare and diagnostic centers. These three parameters are calculated and forecast is developed. Installation base is calculated as average number of units per facility; while sales for particular year is calculated from number of new and replace units. Secondary data is collected through various supply chain intermediaries and opinion leaders to arrive at installation and sales rate. These techniques help our analysts in validating market and developed market estimates and forecast.

We do forecast on basis of several parameters such as market drivers, market opportunities, industry trends government regulations, raw materials supply and trade dynamics to ensure relevance of forecast with market scenario. With increasing need to granulized information, we used bottom-up methodology for forecasting where we evaluate each regional segment differently and combined all forecast to develop final market forecast.

Data Validation

We believe primary research is a very important tool in analyzing and forecasting different markets. In order to make sure accuracy of our findings, our team conducts primary interviews at every stage of research to gain deep insights into current business environment and future trends and key developments in market. This includes use of various methods such as telephonic interviews, focus groups, face to face interviews and questionnaires to validate our research from all aspects. We validate our data through primary research from key industry leaders such as CEO, product managers, marketing managers, suppliers, distributors, and consumers are frequently interviewed. These interviews provide valuable insights which help us to have better market understanding besides validating our estimates and forecast.

Data Triangulation

data triangulation

Industry Analysis

Qualitative Data

Quantitative Data (2017-2025)
  • Market Dynamics (Drivers, Restraints, and Challenges)
  • Industry Trend Analysis
  • Market Opportunities
  • Government Policies and Regulations, Patent Analysis, and Reimbursement Policies
  • Porter’s Five Forces and PESTLE Analysis
  • Key Developments and Competitive Landscape
  • Market Assessment and Forecast
  • Market Assessment and Forecast, By Product
  • Market Assessment and Forecast, By Technology
  • Market Assessment and Forecast, By Application
  • Market Assessment and Forecast, By End User
  • Market Assessment and Forecast, By Region/Country

License Type

For Any Assistance

*
*
*
*
*